BAGSVAERD, DENMARK--(Marketwire - February 14, 2011) -
Company Announcement no 8 2011: http://hugin.info/2013/R/1488630/423964.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE
[HUG#1488630]
Further information:
Media:
Anne Margrethe Hauge
Tel: (+45) 4442 3450
Email Contact
In North America:
Ken Inchausti
Tel: (+1) 609 514 8316
Email Contact
Investors:
Klaus Bulow Davidsen
Tel: (+45) 4442 3176
Email Contact
Kasper Roseeuw Poulsen
Tel: (+45) 4442 4471
Email Contact
Jannick Lindegaard
Tel: (+45) 4442 4765
Email Contact
In North America:
Hans Rommer
Tel: (+1) 609 919 7937
Email Contact